CLINICAL CASES IN MS

CLINICAL CASES IN MS – WORSENING SYMPTOMS PRIOR TO OCRELIZUMAB INFUSION

 

Click here to watch Dr. Virginia Devonshire discuss the case and the responses to the survey.

Thomas, 38, is a chemical engineer who initially presented in 2019 with optic neuritis followed two months later by a myelopathic episode. MRI was highly active with two gadolinium-enhancing T1 and multiple T2 lesions. EDSS was 2.5 (optic 1, sensory 2, bladder 2). Thomas had no relevant medical conditions other than obesity; his body weight was 120 kg (BMI 34 kg/m2) at presentation. Read More

CLINICAL CASES IN MS – A DIAGNOSTIC DILEMMA

 

Click here to watch Dr. Daniel Selchen discuss the case and the responses to the survey.

Ken, a 53-year-old man, was initially seen in 2017 following onset of painful spasms in R leg and probable clonus while driving his car. He developed R leg weakness and band-like discomfort across his chest. He was worked up for stroke and cardiac issues and all investigations were negative. He had a prior history of asthma with nasal polyps and NSAID-associated dyspnea.

Read More

CLINICAL CASES IN MS – A case of worsening mobility during the pandemic

 

Click here to watch Dr. Julie Prévost discuss the case and the responses to the survey.

Michelle, 46, is a bank manager who was diagnosed with MS in 1996. She was initially treated with interferon-beta-1a 44 ug. She experienced ongoing clinical and radiological activity and was switched to natalizumab in 2013. She remained stable for seven years. In February 2020, Michelle noted that she used to be able to walk 2 km but could now only manage about 1 km. Her EDSS score showed no change over the past year. EDSS score was 3.0 (motor 2, cerebellar 2, sensory 2). She was started on 4-aminopyridine but obtained no benefit. Read More

CLINICAL CASES IN MS – AN OLDER PATIENT WITH STABLE DISEASE

 

Click here to watch Dr. Courtney Casserly discuss the case and the responses to the survey.

Janet, 58, currently works full-time running an animal grooming business. She is married with two adult children.  She was diagnosed in 1997 with RRMS after presenting with two mild relapses. MRI at that time revealed a low T2 burden of disease. She was initially hesitant about starting treatment. In 2003, she initiated therapy with interferon-beta-1b after experiencing a moderately-severe relapse with some residual disability. EDSS was 1.5. Read More